Ranjit Bindra Email

Chief Scientific Advisor & Scientific co-founder . Cybrexa

New Haven, CT

Location

LinkedIn

Current Roles

Employees:
28
Revenue:
$4.3M
About
Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalexâ„¢ platform. The Company's lead candidate, CBX-12, an alphalexâ„¢-exatecan conjugate, is expected to enter Phase I in 2021 in advanced solid tumors. Cybrexa also has other preclinical toxin conjugate programs as well as synthetic lethality programs. Cybrexa was founded by physician-scientists and has an experienced management team that has built numerous successful life sciences companies. For more information about Cybrexa, please visit www.cybrexa.com.
Cybrexa Address
395 Winchester Ave.
New Haven, CT
United States
Cybrexa Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.